Aligos Therapeutics (ALGS) Net Margin Growth (1y) (2022 - 2026)
Aligos Therapeutics (ALGS) Net Margin Growth (1y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
3,245.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
1,120.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Aligos Therapeutics |
54.72 Mn |
-25.11 Mn |
- |
-1.47 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-1.47 Mn |
| Dec 31, 2025 |
179,220.00 |
| Sep 30, 2025 |
-271,529.00 |
| Jun 30, 2025 |
-212,084.00 |
| Mar 31, 2025 |
1.89 Mn |
| Dec 31, 2024 |
-1.28 Mn |
| Sep 30, 2024 |
-70,316.00 |
| Jun 30, 2024 |
91,461.00 |
| Mar 31, 2024 |
-413,479.00 |
| Dec 31, 2023 |
-11,158.00 |
| Mar 31, 2023 |
49,656.00 |
| Dec 31, 2022 |
965,752.00 |
| Mar 31, 2022 |
165,584.00 |
